X

Trial Profile

A Phase 1b/2a Multicenter Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 19 Jun 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Idronoxil (Primary)
Indications Advanced breast cancer; Male breast cancer; Non-small cell lung cancer; Prostate cancer; Solid tumours
Focus Adverse reactions; Therapeutic Use
Sponsors Noxopharm

Most Recent Events

28 Jun 2023 This trial has been completed in Hungary (Date of the global end of the trial: 7 June 2023).
12 Jun 2023 Status changed from active, no longer recruiting to discontinued due to slow recruitment.
27 Apr 2023 Planned End Date changed from 28 Feb 2024 to 31 Aug 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com